Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Francis, Steffi Pulikodan
- Enhancing the Bioavailability of a Natural Product Curcumin to increase the Therapeutic Efficacy by a Novel Formulation Technology
Abstract Views :212 |
PDF Views:0
Authors
Affiliations
1 Cauvery College for Women, Annamalai Nagar, Trichy - 18. West campus, PRIST University, Thanjavur - 613403, Tamil Nadu, IN
2 Centre for Research and Development, West campus, PRIST University, Thanjavur - 613403, Tamil Nadu, IN
1 Cauvery College for Women, Annamalai Nagar, Trichy - 18. West campus, PRIST University, Thanjavur - 613403, Tamil Nadu, IN
2 Centre for Research and Development, West campus, PRIST University, Thanjavur - 613403, Tamil Nadu, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 6 (2019), Pagination: 2615-2620Abstract
Curcumin is found in the rhizome of Curcuma longa. It exhibits various biological activities like anti-cancer, anti-inflammatory, anti-viral, anti-bacterial, anti-oxidant and nematocidal activities. Due to its poor solubility there is a need to formulate this curcumin for better bioavailability. Curcumin was extracted by acetone using soxhlet apparatus and evaporated by means of vacuum rotary evaporator. The presence of curcumin was confirmed by differential scanning calorimetry. Nanosuspension was prepared by bottom up method using acetone and water solvent system. Stabilizers were added under optimized conditions in order to achieve suitable quality of nanosuspension. Then it was analyzed using particle size and zeta potential analyzers for acceptable quality. Pharmacokinetic property and bioavailability are important phenomena that determine the suitability of formulation in therapeutic application. Hence, a study was performed for the prepared nanosuspension formulation. There were two groups of animals considered. One for the formulated curcumin another for non-formulated raw curcumin which served as control. Animals were administrated orally once with 250 mg /kg body weight of respective test drugs and blood samples were collected every 30 min till 180 min. Curcumin in the samples were quantified by HPLC. The Area Under the Concentration time curve (AUC) was drawn and evaluated statistically using ‘t’ test for significant improvement in bioavailability of formulation. Results showed that there is a significant (P< 0.05) improvement in bioavailability and specific pharmacokinetic property for the prepared formulation.Keywords
Curcumin, Cancer, Nanosuspension, Pharmacokinetics, Oral Bioavailability.
References
- H. J. Mehta, V. Patel, and R. T. Sadikot, Curcumin and lung cancer-a review, Target Oncol., (2014).
- M. L. Lestari and G. Indrayanto, Curcumin, Profiles. Drug Subst. Excip. Relat Methodol., 39 (2014) 113-204.
- S. S. Bansal, H. Kausar, M. V. Vadhanam, S. Ravoori, J. Pan, S. N. Rai, and R. C. Gupta, Curcumin Implants, not Curcumin Diet Inhibits Estrogen-Induced Mammary Carcinogenesis in ACI rats, Cancer Prev. Res. (Phila), (2014).
- L. Das and M. Vinayak, Long term effect of curcumin down regulates expression of TNF-alpha and IL-6 via modulation of ETS and NF-kappaB transcription factor in liver of lymphoma bearing mice, Leuk. Lymphoma, (2014).
- D. Chin, P. Huebbe, J. Frank, G. Rimbach, and K. Pallauf, Curcumin may impair iron status when fed to mice for six months, Redox. Biol., 2 (2014) 563-569.
- G. M. Cragg, P. G. Grothaus, and D. J. Newman, New Horizons for Old Drugs and Drug Leads, J. Nat. Prod., (2014).
- H. F. Ji and L. Shen, Can improving bioavailability improve the bioactivity of curcumin?, Trends Pharmacol. Sci., 35 (2014) 265-266.
- A. Semalty, Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis, Expert. Opin. Drug Deliv., 11 (2014) 1255-1272.
- C. Kuehl, N. El-Gendy, and C. Berkland, Nano Clusters surface area allows nanoparticle dissolution with microparticle properties, J. Pharm. Sci., 103 (2014) 1787-1798.
- W. W. Chin, J. Parmentier, M. Widzinski, E. H. Tan, and R. Gokhale, A Brief Literature and Patent Review of Nanosuspensions to a Final Drug Product, J. Pharm. Sci., (2014).
- Y. Wang, Y. Zheng, L. Zhang, Q. Wang, and D. Zhang, Stability of nanosuspensions in drug delivery, J. Control Release, 172 (2013) 1126-1141.
- S. Muthuirulappan and S. P. Francis, Anti-cancer mechanism and possibility of nano-suspension formulations for a marine algae product fucoxanthin, Asian Pac. J. Cancer Prev., 14 (2013) 2213-2216.
- V. B. Patravale, A. A. Date, and R. M. Kulkarni, Nanosuspensions: a promising drug delivery strategy, J. Pharm. Pharmacol., 56 (2004) 827-840.
- D. Chin, P. Huebbe, J. Frank, G. Rimbach, and K. Pallauf, Curcumin may impair iron status when fed to mice for six months, Redox. Biol., 2 (2014) 563-569.
- M. S. Freag, Y. S. Elnaggar, and O. Y. Abdallah, Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation, Int. J. Pharm., 454 (2013) 462-471.
- H. S. Ali, P. York, A. M. Ali, and N. Blagden, Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling, J. Control Release, 149 (2011) 175-181.
- Y. Zu, W. Wu, X. Zhao, Y. Li, W. Wang, C. Zhong, Y. Zhang, and X. Zhao, Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique, Int. J. Pharm., 471 (2014) 366-376.
- A. Bajaj, M. R. Rao, A. Pardeshi, and D. Sali, Nano crystallization by evaporative antisolvent technique for solubility and bioavailability enhancement of telmisartan, AAPS. Pharm Sci Tech., 13 (2012) 1331-1340.
- Y. Gao, Z. Li, M. Sun, C. Guo, A. Yu, Y. Xi, J. Cui, H. Lou, and G. Zhai, Preparation and characterization of intravenously injectable curcumin nanosuspension, Drug Deliv., 18 (2011) 131-142.
- Y. Q. Liu, G. H. He, H. L. Li, J. C. He, E. F. Feng, L. Bai, C. Y. Wang, and G. L. Xu, Plasma pharmacokinetics and tissue distribution study of roemerine in rats by liquid chromatography with tandem mass spectrometry (LC-MS/MS), J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 969 (2014) 249-255.
- Y. B. Pawar, H. Purohit, G. R. Valicherla, B. Munjal, S. V. Lale, S. B. Patel, and A. K. Bansal, Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach, Int. J. Pharm., 436 (2012) 617-623.
- A. C. Anselmo and S. Mitragotri, An overview of clinical and commercial impact of drug delivery systems, J. Control Release, (2014).
- D. Gugulothu, A. Kulkarni, V. Patravale, and P. Dandekar, pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model, J. Pharm. Sci., 103 (2014) 687-696.
- M. Kanai, Therapeutic applications of curcumin for patients with pancreatic cancer, World J. Gastroenterol., 20 (2014) 9384-9391.
- P.Manish, P.Gopkumar, G.Sridevi , C.C. Behera, P.Sujit. Development and Validation of RP-HPLC Method for Simultaneous Determination of Resveratrol and Curcumin in Pure Form. Research J. Pharm. and Tech. 6 (2013) 990-992.
- Pratik J. Purohit, Pankaj P. Kapupara, Ketan V. Shah. Development and Validation of Analytical Method for Simultaneous Estimation of Curcumin and Gallic Acid in Different Polyherbal Formulations by HPLC. Research J. Pharm. and Tech. 7(2014) 749-753.
- J. Chimakurthy, T. Murthy, L. Upadhyay. Effect of Curcumin on Sub-Therapeutic Doses of AED’S And Long Term Memory In MES Induced GTC Type of Seizures in Rats. Research J. Pharm. and Tech. 1(2008) 401-404.
- TE. Gopala Krishna Murthy, C. Mayuren. Pharmacokinetics of Gliclazide Alone and in Combination with Irbesartan in Rabbits. Research J. Pharm. and Tech. 1(2008) 418-421.
- Velingkar .VS, Dandekar. VD. Microwave-Assisted Synthesis and Evaluation of Anticancer Activity of Substituted Acridone Analogues. Research J. Pharm. and Tech.2 (2009) 366-370.
- RA. Hajare, KS. Parwani, SA. Bajad, NA. Chandekar, AV. Chandewar. Breast Cancer and Indole -3-Carbinol: Controversy of Estrogen Level and Enzyme Elastase. Research J. Pharm. and Tech.2 (2009) 439-440.
- SR. Shinde, S I. Bhoir, NS. Pawar, AM. Bhagwat. Quantitation of Valsartan in Human Plasma by High Performance Liquid Chromatography with Fluorescence Detection and its Application to Bioequivalence Study. Research J. Pharm. and Tech.2 (2009) 487-490.
- Bhasker. S, Sandeep. G, Ranganath. YS. Future of Cancer Therapy-COX-2 Inhibitors: A Review. Research J. Pharm. and Tech.2 (2009) 617-620.
- V. Shinde, P. Amsa, S. Tamizharasi, D. Karthikeyan, T. Sivakumar, A. Kosalge. Nanosuspensions: A Promising Drug Delivery Strategy. Research J. Pharm. and Tech. 3(2010) 39-44.
- S. Chowdhury, S. Majumdar. Fixed Dose Combination - its Rationality and Safety. Research J. Pharm. and Tech.3 (2010) 705-708.